{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:35:09Z","timestamp":1791837309158,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009068.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000}}],"reference-count":137,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009068.pub3","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T17:52:29Z","timestamp":1539712349000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy"],"prefix":"10.1002","volume":"2020","author":[{"given":"John P","family":"Bourke","sequence":"first","affiliation":[{"name":"Freeman Hospital; Department of Cardiology; Freeman Road Newcastle Upon Tyne UK NE7 DN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teofila","family":"Bueser","sequence":"additional","affiliation":[{"name":"King's College London; Florence Nightingale Faculty of Nursing & Midwifery; London UK SE1 8WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaline","family":"Quinlivan","sequence":"additional","affiliation":[{"name":"UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery and Great Ormond Street; MRC Centre for Neuromuscular Diseases and Dubowitz Neuromuscular Centre; PO Box 114 London UK WC1B 3BN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"10.1002\/14651858.CD009068.pub3-BIB0001|cit1","first-page":"1","article-title":"A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"5","author":"Allen","year":"2013","journal-title":"PLOS Currents Muscular Dystrophy"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0002|cit2","unstructured":"NCT01982695 Cardiomyopathy in DMD: lisinopril vs. losartan clinicaltrials.gov\/ct2\/show\/study\/NCT01982695"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.nmd.2011.02.016","article-title":"Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a randomized placebo-controlled trial","volume":"21","author":"Buyse","year":"2011","journal-title":"Neuromuscular Disorders"},{"issue":"7","key":"10.1002\/14651858.CD009068.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0195-668X(02)00740-6","article-title":"A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies","volume":"24","author":"Cittadini","year":"2003","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"American Heart Journal"},{"issue":"13","key":"10.1002\/14651858.CD009068.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1073\/pnas.82.13.4513","article-title":"Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10","volume":"82","author":"Folkers","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00002060-199509000-00005","article-title":"A management trial for Duchenne cardiomyopathy","volume":"74","author":"Ishikawa","year":"1995","journal-title":"American Journal of Physical Medicine & Rehabilitation"},{"issue":"8","key":"10.1002\/14651858.CD009068.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.70.991","article-title":"Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy","volume":"70","author":"Kajimoto","year":"2006","journal-title":"Circulation Journal"},{"issue":"14","key":"10.1002\/14651858.CD009068.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","article-title":"Carvedilol can prevent cardiac events in Duchenne muscular dystrophy","volume":"49","author":"Matsumura","year":"2010","journal-title":"Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of DMD","volume":"74","author":"Mendell","year":"2013","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00246-007-9113-z","article-title":"Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy","volume":"29","author":"Rhodes","year":"2008","journal-title":"Pediatric Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD009068.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(14)70195-4","article-title":"Safety and efficacy of Drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised placebo controlled phase II study","volume":"13","author":"Voit","year":"2014","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0016|cit16","unstructured":"EUCTR2008-007236-18-IT Effects of cardioprotective therapy, carvedilol vs ramipril, in patients affected by Duchenne and Becker muscular dystrophy. Clinical significance and prognostic value of cardiac magnetic resonance study clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2008-007236-18"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.24214","article-title":"Sildenafil does not improve cardiomyopathy in Duchenne\/Becker muscular dystrophy","volume":"76","author":"Leung","year":"2014","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0018|cit18","unstructured":"NCT01168908 Revatio for heart disease in Duchenne muscular dystrophy and Becker muscular dystrophy (REVERSE-DBMD) clinicaltrials.gov\/show\/NCT01168908"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0019|cit19","unstructured":"IRCT2015070223018N1 Effect of Q10 coenzyme in improving cardiac function en.irct.ir\/trial\/19746"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.19082\/3896","article-title":"Effectiveness of Coenzyme Q10 on echocardiographic parameters of patients with Duchenne muscular dystrophy","volume":"9","author":"Salehi","year":"2017","journal-title":"Electronic Physician"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0021|cit21","unstructured":"NCT01603407 Finding the optimum regimen for Duchenne muscular dystrophy (FOR-DMD) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01603407"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0022|cit22","unstructured":"ISRCTN50395346 A double-blind randomised multi-centre, placebo-controlled trial of combined angiotensin converting enzyme-inhibitor and beta-blocker therapy in preventing the development of cardiomyopathy in genetically characterised males with Duchenne muscular dystrophy without echo-detectable left ventricular dysfunction isrctn.com\/ISRCTN50395346"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0023|cit23","unstructured":"NCT00606775 The preventive efficacy of carvedilol on cardiac dysfunction in Duchenne muscular dystrophy clinicaltrials.gov\/show\/NCT00606775"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0024|cit24","unstructured":"NCT00819845 Ramipril versus carvedilol in Duchenne and Becker patients clinicaltrials.gov\/show\/NCT00819845"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0025|cit25","unstructured":"NCT01126697 Clinical trial of coenzyme Q10 and lisinopril in muscular dystrophies clinicaltrials.gov\/show\/NCT01126697"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0026|cit26","unstructured":"NCT01350154 Effect of modulating the nNOS system on cardiac, muscular and cognitive function in Becker muscular dystrophy patients clinicaltrials.gov\/show\/NCT01350154"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0027|cit27","unstructured":"NCT01648634 Nebivolol for the prevention of left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy (NEBIDYS) clinicaltrials.gov\/show\/NCT01648634"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0028|cit28","unstructured":"NCT02354352 Therapeutic potential for aldosterone inhibition in Duchenne muscular dystrophy https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02354352"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0029|cit29","unstructured":"NCT02432885 Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy - ACE inhibitor therapy trial clinicaltrials.gov\/show\/NCT02432885"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0030|cit30","unstructured":"NCT02485938 HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) (HOPE) clinicaltrials.gov\/show\/NCT02485938"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0031|cit31","unstructured":"NCT03340675 Oral ifetroban in subjects with Duchenne muscular dystrophy (DMD) clinicaltrials.gov\/show\/NCT03340675"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0032|cit32","unstructured":"NCT03406780 A study of CAP-1002 in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy (HOPE-2) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03406780"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0033|cit33","unstructured":"NCT03439670 A study to assess the efficacy and safety of vamorolone in boys with Duchenne muscular dystrophy (DMD) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03439670"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/B978-0-444-59565-2.00020-4","article-title":"Innovating therapies for muscle diseases","volume":"113","author":"Aartsma-Rus","year":"2013","journal-title":"Handbook of Clinical Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5603\/CJ.a2014.0057","article-title":"I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: impact on the exercise tolerance and quality of life","volume":"22","author":"Abdel-Salam","year":"2014","journal-title":"Cardiology Journal"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0036|cit36","first-page":"526","article-title":"Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failure","volume":"2","author":"Abraham","year":"2014","journal-title":"JACC: Heart Failure"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009068.pub3-BIB0037|cit37","first-page":"5275","article-title":"Heart rate reduction strategy with Ivabradine in reducing acute heart failure in Duchenne dilated cardiomyopathy","volume":"38","author":"Adorisio","year":"2017","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0038|cit38","first-page":"227","article-title":"Cardiac resynchronisation therapy in Becker muscular dystrophy","volume":"54","author":"Andrikopoulos","year":"2013","journal-title":"Hellenic Journal of Cardiology"},{"issue":"1-2","key":"10.1002\/14651858.CD009068.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0022-510X(96)00144-X","article-title":"Prognostic factors in mild dystrophinopathies","volume":"142","author":"Angelini","year":"1996","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD009068.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/oxfordjournals.eurheartj.a060343","article-title":"The heart in Duchenne muscular dystrophy: a non-invasive study","volume":"13","author":"Backman","year":"1992","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jpeds.2013.05.060","article-title":"Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy","volume":"163","author":"Barber","year":"2013","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00343141","article-title":"Eine neue X-chromasomale Muskeldystrophie","volume":"193","author":"Becker","year":"1955","journal-title":"Archiv fur Psychiatrie und Nervenkrankheiten"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.CIR.86.1.147","article-title":"Expression and localization of dystrophin in human cardiac Purkinje fibres","volume":"86","author":"Bies","year":"1992","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Bigggar","year":"2006","journal-title":"Neuromuscular Disorders"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2217\/fca-2016-0030","article-title":"Sunshine Heart C-Pulse: device for NYHA III and ambulatory class IV heart failure","volume":"12","author":"Black","year":"2016","journal-title":"Future Cardiolology"},{"issue":"7","key":"10.1002\/14651858.CD009068.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"969-76","DOI":"10.1161\/CIRCULATIONAHA.105.543678","article-title":"Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy","volume":"113","author":"Bleeker","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"e003529","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529","article-title":"Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis","volume":"10","author":"Burnett","year":"2017","journal-title":"Circulation. Heart Failure"},{"issue":"8748","key":"10.1002\/14651858.CD009068.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0140-6736(91)92671-N","article-title":"Prevalence and incidence of Becker muscular dystrophy","volume":"337","author":"Bushby","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0960-8966(93)90042-I","article-title":"Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy","volume":"3","author":"Bushby","year":"1993","journal-title":"Neuromuscular Disorders"},{"issue":"8","key":"10.1002\/14651858.CD009068.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00314256","article-title":"Cardiac transplantation in Becker muscular dystrophy","volume":"235","author":"Casazza","year":"1988","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/clc.20757","article-title":"Prophylactic implantation of cardioverter defibrillator in idiopathic non-ischaemic cardiomyopathy for the primary prevention of death: a narrative review","volume":"33","author":"Cevik","year":"2010","journal-title":"Clinical Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9149(01)02261-5","article-title":"Relation of aldosterone 'escape' despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy","volume":"89","author":"Cicoira","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD009068.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0002-9149(02)02195-1","article-title":"Prognostic value of echocardiograms, ventricular late potentials, ventricular arrhythmias and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy","volume":"89","author":"Corrado","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD009068.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1096\/fj.01-0030fje","article-title":"Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury","volume":"15","author":"Danialou","year":"2001","journal-title":"FASEB Journal"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-8703(94)90672-6","article-title":"Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an electrocardiographic study","volume":"127","author":"Kermadec","year":"1994","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mus.880150510","article-title":"The heart in Becker muscular dystrophy, fascioscapulohumeral muscular dystrophy and Bethlem myopathy","volume":"15","author":"Visser","year":"1992","journal-title":"Muscle & Nerve"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.1989.00520420127038","article-title":"Cardiac transplant in a patient with muscular dystrophy and cardiomyopathy","volume":"46","author":"Donofrio","year":"1989","journal-title":"Archives of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD009068.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1399-0004.1976.tb00033.x","article-title":"Clinical studies in benign (Becker type) X-linked muscular dystrophy","volume":"10","author":"Emery","year":"1976","journal-title":"Clinical Genetics"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0060|cit60","volume-title":"Duchenne Muscular Dystrophy","author":"Emery","year":"2003"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.transproceed.2009.12.005","article-title":"Results of heart transplantation: 16 years experience in a center in Argentina","volume":"42","author":"Fararolo","year":"2010","journal-title":"Transplantation Proceedings"},{"issue":"11","key":"10.1002\/14651858.CD009068.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/europace\/eun264","article-title":"Complete atrioventricular block in Duchenne muscular dystrophy","volume":"10","author":"Fayssoil","year":"2008","journal-title":"Europace"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0960-8966(99)00015-2","article-title":"X-linked dilated cardiomyopathy and the dystrophin gene","volume":"9","author":"Ferlini","year":"1999","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000068446","article-title":"The heart in human dystrophinopathies","volume":"99","author":"Finserer","year":"2003","journal-title":"Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0065|cit65","first-page":"311","article-title":"The identification of point mutations in Duchenne muscular dystrophy patients by using reverse transcription PCR and the protein truncation test","volume":"57","author":"Gardner","year":"1989","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurpsyc.1923.02190190064006","article-title":"The pathological findings in the heart muscle in progressive muscular dystrophy","volume":"9","author":"Globus","year":"1923","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0067|cit67","unstructured":"McMaster University (developed by Evidence Prime, Inc.) GRADEpro GDT: GRADEpro Guideline Development Tool 2015"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/abio.2001.5096","article-title":"Metabolic profiling of genetic disorders: a multi-tissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue","volume":"293","author":"Griffin","year":"2001","journal-title":"Analytical Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003040.pub2","article-title":"Angiotensin receptor blockers for heart failure","author":"Heran","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0002-8703(78)90358-7","article-title":"Sequence of cardiac changes in Duchenne muscular dystrophy","volume":"95","author":"Heymsfield","year":"1978","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0071|cit71","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/hrt.2007.125948","article-title":"Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland","volume":"94","author":"Holloway","year":"2008","journal-title":"Heart"},{"issue":"10","key":"10.1002\/14651858.CD009068.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s004150050163","article-title":"Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period","volume":"244","author":"Hoogerwaard","year":"1997","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-8966(99)00018-8","article-title":"Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy","volume":"9","author":"Hoogerwaard","year":"1999","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1532-429X-13-12","article-title":"Presence of mechanical dyssynchrony in Duchenne muscular dystrophy","volume":"13","author":"Hor","year":"2011","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/01.JIM.0000446835.98223.ce","article-title":"Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies","volume":"62","author":"Hussein","year":"2014","journal-title":"Journal of Investigative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nmd.2014.08.008","article-title":"Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: management and lessons learned","volume":"25","author":"Iodice","year":"2015","journal-title":"Neuromuscular Disorders"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1442-200X.1997.tb03668.x","article-title":"Early cardiac failure in a child with Becker muscular dystrophy is due to an abnormally low amount of dystrophin transcript lacking exon 13","volume":"39","author":"Ishigaki","year":"1997","journal-title":"Acta Paediatrica Japonica"},{"issue":"8","key":"10.1002\/14651858.CD009068.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00314767","article-title":"A manifesting carrier of Duchenne muscular dystrophy with severe myocardial symptoms","volume":"237","author":"Kamakura","year":"1990","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0080|cit80","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Human Genetics"},{"issue":"8","key":"10.1002\/14651858.CD009068.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/IMCRJ.S87512","article-title":"Cardiac resynchronisation therapy in a young patient with Duchenne muscular dystrophy","volume":"21","author":"Kono","year":"2015","journal-title":"International Medical Case Reports Journal"},{"issue":"9","key":"10.1002\/14651858.CD009068.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"684","DOI":"10.5692\/clinicalneurol.52.685","article-title":"Complete atrioventricular block in Duchenne muscular dystrophy","volume":"52","author":"Kuru","year":"2012","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4070\/kcj.2012.42.3.184","article-title":"The effect of enalapril and carvedilol on left ventricular function in middle childhood and adolescent patients with muscular dystrophy","volume":"42","author":"Kwon","year":"2012","journal-title":"Korean Circulation Journal"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1212\/WNL.30.5.497","article-title":"Electrocardiographic abnormalities in carriers of Duchenne muscular dystrophy","volume":"30","author":"Lane","year":"1980","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1067\/mhj.2001.114804","article-title":"Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function","volume":"141","author":"Lanza","year":"2001","journal-title":"American Heart Journal"},{"issue":"4879","key":"10.1002\/14651858.CD009068.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1126\/science.3055295","article-title":"Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy","volume":"242","author":"Malhotra","year":"1988","journal-title":"Science"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","article-title":"Carvedilol can prevent cardiac events in Duchenne muscular dystrophy","volume":"49","author":"Matsumara","year":"2010","journal-title":"Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003725.pub4","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","author":"Matthews","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD009068.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","article-title":"Myocardial involvement is very frequent in patients affected with subclinical Becker's muscular dystrophy","volume":"94","author":"Melacini","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Annals of Neurology"},{"issue":"6304","key":"10.1002\/14651858.CD009068.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/349069a0","article-title":"Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse","volume":"349","author":"Menke","year":"1991","journal-title":"Nature"},{"issue":"8","key":"10.1002\/14651858.CD009068.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/hrt.2003.021113","article-title":"Reliable detection of early myocardial dysfunction by tissue Doppler echocardiography in Becker muscular dystrophy","volume":"90","author":"Meune","year":"2004","journal-title":"Heart"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/hrt.66.6.452","article-title":"Echocardiographic evaluation of fibrous replacement in the myocardium of patients with Duchenne muscular dystrophy","volume":"66","author":"Miyoshi","year":"1991","journal-title":"British Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00246-001-0040-0","article-title":"plasma levels of Natriuretic peptides and echocardiographic parameters in Duchenne's muscular dystrophy","volume":"23","author":"Mori","year":"2002","journal-title":"Paediatric Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1540-8175.2007.00437.x","article-title":"Myocardial strain imaging for early detection of cardiac involvement in patients with Duchenne's progressive muscular dystrophy","volume":"24","author":"Mori","year":"2007","journal-title":"Echocardiography"},{"issue":"2-3","key":"10.1002\/14651858.CD009068.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-510X(87)90092-X","article-title":"Life spans of Duchenne muscular dystrophy patients in the hospital care programme in Japan","volume":"81","author":"Mukoyama","year":"1987","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/hrt.78.6.608","article-title":"Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy","volume":"78","author":"Muntoni","year":"1997","journal-title":"Heart"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00019052-200310000-00003","article-title":"Cardiomyopathy in muscular dystrophies","volume":"16","author":"Muntoni","year":"2003","journal-title":"Current Opinion in Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.880060403","article-title":"Prospective study of X-linked progressive muscular dystrophy in Campania","volume":"6","author":"Nigro","year":"1983","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.880180304","article-title":"Evaluation of the cardiomyopathy in Becker muscular dystrophy","volume":"18","author":"Nigro","year":"1995","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/heart.87.2.156","article-title":"Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients","volume":"87","author":"Nigro","year":"2002","journal-title":"Heart"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0147-9563(98)90057-7","article-title":"Dominant R wave in lead V1","volume":"27","author":"Nikol\u00edc","year":"1998","journal-title":"Heart & Lung"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0960-8966(02)00197-9","article-title":"Cardiac assessment in childhood carriers of Duchenne and Becker muscular dystrophies","volume":"13","author":"Nolan","year":"2003","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/hrt.72.4.344","article-title":"Dilated cardiomyopathy and the dystrophin gene: an illustrated review","volume":"72","author":"Oldfors","year":"1994","journal-title":"British Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5582\/irdr.2017.01024","article-title":"Heart transplantation in patients with dystrophinopathic cardiomyopathy: review of the literature and personal series","volume":"6","author":"Papa","year":"2017","journal-title":"Intractable & Rare Diseases Research"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/01.CIR.69.1.33","article-title":"Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging","volume":"69","author":"Perloff","year":"1984","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004571.pub2","article-title":"Calcium antagonists for Duchenne muscular dystrophy","author":"Phillips","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009068.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"European Journal of Heart Failure"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00868396","article-title":"Becker muscular dystrophy presenting with complete heart block in the sixth decade","volume":"242","author":"Quinlivan","year":"1995","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0960-8966(96)00007-7","article-title":"Cardiac function, metabolism and perfusion in Duchenne and Becker muscular dystrophy","volume":"6","author":"Quinlivan","year":"1996","journal-title":"Neuromuscular Disorders"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0112|cit112","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MAT.0000000000000050","article-title":"Implantation of the HeartMate II and HeartWare left ventricular assist devices in patients with Duchenne muscular dystrophy: lessons learned from the first applications","volume":"60","author":"Ryan","year":"2014","journal-title":"ASAIO Journal"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0114|cit114","first-page":"210","article-title":"A case of Becker muscular dystrophy presenting cardiac failure as the initial symptom","volume":"30","author":"Sakata","year":"1990","journal-title":"Rinsho Shinkeigaku"},{"issue":"9","key":"10.1002\/14651858.CD009068.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","article-title":"All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy","volume":"61","author":"Schram","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"18","key":"10.1002\/14651858.CD009068.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jacc.2006.10.078","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy","volume":"49","author":"Silva","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9149(02)03429-X","article-title":"Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy","volume":"91","author":"Silversides","year":"2003","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD009068.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.echo.2016.07.001","article-title":"Evaluation of echocardiographic measures of left ventricular function in patients with Duchenne muscular Dystrophy","volume":"29","author":"Soslow","year":"2016","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"8","key":"10.1002\/14651858.CD009068.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.echo.2015.03.003","article-title":"Feasibility and reproducibility of echocardiographic measures in children with muscular dystrophies","volume":"28","author":"Spurney","year":"2015","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1532-429X-15-67","article-title":"Left ventricular non-compaction in Duchenne muscular dystrophy","volume":"15","author":"Stabile","year":"2013","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"issue":"3","key":"10.1002\/14651858.CD009068.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/hrt.68.9.304","article-title":"Subclinical cardiomyopathy in Becker muscular dystrophy","volume":"68","author":"Steare","year":"1992","journal-title":"British Heart Journal"},{"issue":"9744","key":"10.1002\/14651858.CD009068.pub3-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD009068.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/eurheartj\/14.5.669","article-title":"Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy","volume":"14","author":"Takenaka","year":"1993","journal-title":"European Heart Journal"},{"issue":"11","key":"10.1002\/14651858.CD009068.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1253\/jcj.43.974","article-title":"Natural course of cardiomyopathy in Duchenne muscular dystrophy","volume":"43","author":"Tanaka","year":"1979","journal-title":"Japanese Circulation Journal"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","article-title":"X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus","volume":"87","author":"Towbin","year":"1993","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1510\/icvts.2008.183707","article-title":"Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?","volume":"7","author":"Turley","year":"2008","journal-title":"Interactive Cardiovascular and Thoracic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD009068.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","article-title":"The PedsQL: measurement model for the pediatric quality of life inventory","volume":"37","author":"Varni","year":"1999","journal-title":"Medical Care"},{"issue":"13","key":"10.1002\/14651858.CD009068.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/01.wnl.0000257819.47628.41","article-title":"Construction and validation of a quality of life questionnaire for Neuromuscular Disease (INQol)","volume":"68","author":"Vincent","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD009068.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2012.02.064","article-title":"Effects of angiotensin-converting enzyme inhibitors and\/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy","volume":"110","author":"Viollet","year":"2012","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbadis.2006.06.009","article-title":"Current treatment of adult Duchenne muscular dystrophy","volume":"1772","author":"Wagner","year":"2007","journal-title":"Biochemica et Biophysica Acta"},{"key":"10.1002\/14651858.CD009068.pub3-BIB0131|cit131","volume-title":"User's Manual for the SF-36v2TM Health Survey","author":"Ware","year":"2007"},{"issue":"13","key":"10.1002\/14651858.CD009068.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1093\/hmg\/ddt112","article-title":"Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy","volume":"22","author":"Wasala","year":"2013","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.healun.2009.08.030","article-title":"Clinical outcomes after cardiac transplantation in muscular dystrophy patients","volume":"29","author":"Wu","year":"2010","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD009068.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0002-9149(88)91076-4","article-title":"A comparative study of thallium-201 single-photon emission computed tomography and electrocardiography in Duchenne and other types of muscular dystrophy","volume":"61","author":"Yamamoto","year":"1988","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD009068.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD009068.pub3-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009068","article-title":"Prevention and treatment for cardiac complications in Duchenne and Becker muscular dystrophy","author":"Quinlivan","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD009068.pub3-BIB0137|cit137","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009068.pub2","article-title":"Prevention and treatment for cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy","author":"Quinlivan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009068.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T04:49:37Z","timestamp":1666846177000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009068.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":137,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009068.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]}}}